In an interview with the Toronto Star, veteran energy policy analyst Amory Lovins said that he had spoken with former Greenpeace co-founder turned nuclear power promoter Patrick Moore and concluded that "he's not well informed about energy alternatives." Earlier this year, the Nuclear Energy Institute established a front group, the Clean and Safe Energy Coaltion, with Moore as its co-chair. The group promotes nuclear power as a "solution" to global warming. Lovins referred to his recent Nuclear Energy International article, which showed that "if you spent 10 cents (U.S.) to make and deliver a new nuclear kilowatt-hour ... you can displace 1 kilowatt-hour of coal power. That's what Patrick is talking about. ... If you spend the same 10 cents (U.S.) instead on micropower or efficient use, you get two to 10 times as much coal displacement for the same money, because those options are cheaper -- you get more per dollar. They're also faster, so you get more carbon displacement, coal displacement, per year."

British war photographer Sean Smith spent nearly six weeks with the 101st Division of the U.S. army in Iraq and has produced an eloquent short film which explodes the myth around the claims that U.S.-trained Iraqis are preparing to take control of their own country. In fact, Shia militias loyal to fundamentalist cleric Moqtada al-Sadr seem to be ready, willing and able to seize power, while Sunni insurgents believed to belong to al-Qaida are so emboldened that they have been publicly staging military-like parades within striking distance of U.S. forces stationed in nearby bases. According to former Bush administration foreign policy official Richard N. Haass, the situation is reaching a "tipping point" both in Iraq and in U.S. politics, and the administration's current strategy "has virtually no chance of succeeding."

Cancer United, a cancer patient group created and launched by the PR firm Weber Shandwick with funding from the drug company Roche, has got off to a rocky start. On its website the group states that it aims to run an 18-month-long campaign for more uniform cancer treatments across the European Union. However, before the group was launched, it was revealed that the study it relies on was also funded by Roche. The study by the Karolinska Institute in Stockholm argues that survival rates increase the more a country spends on drugs. Michel Coleman from the London School of Hygiene and Tropical Medicine told the Guardian that the study was "woefully simplistic research." A Labor member of parliament, Ian Gibson, resigned from the group after discovering Roche's role. "I feel very silly and stupid," he said. The press conference convened in Brussels to announce the new group was "sparsely attended."